CIPS HPA in Kenya
CIPS HPA has worked in Kenya since 2018, starting with support for the Kenya Medical Supplies Authority (KEMSA), a state corporation under the Kenyan Ministry of Health that is mandated to procure, warehouse and distribute health products and technologies (HPTs) for prescribed public health programs, the national strategic stock reserves, prescribed essential health packages and national referral hospitals.
Support was then expanded to include Kenyan counties that procure some of their HPTs from KEMSA, MEDS and directly from other suppliers. The CIPS HPA programme was initiated in Murang’a and Laikipia counties in 2021 and in late 2022 expanded to include Kakamega, Isiolo, Nakuru and Trans Nzoia counties.
Jump to section
CIPS HPA’s work follows the proven CIPS Procurement Excellence methodology
1.
2.
3.
4.
The diagnostic uses a 5-point maturity scale. KEMSA and the counties assessed were all operating between ad hoc and tactical levels against the standard
The key areas for improvement identified for KEMSA and for the counties included:
CIPS HPA technical assistance has therefore focused primarily – though not exclusively – on these areas.
For example, CIPS HPA created procurement frameworks for pre-approving suppliers, reducing the time it takes to procure essential supplies and ensuring more consistent pricing.
CIPS HPA has also supported county health procurement teams in developing a quantification strategy, aimed at improved forecasting of key commodities that the county purchases on behalf of health facilities. Forecasting is critical in order to ensure the healthcare budget covers requirements (which in most cases it does not) and to ensure availability and reduce waste through product expiry.
CIPS HPA has additionally provided technical assistance to Kenyan public healthcare organisations in projects including:
What CIPS HPA has achieved in Kenya
Increase in medicines availability
Increase in availability of critical medicines between 40% and 100% across different Kenyan counties
Reduction in prices of critical medicines
Price improvements of between 30% and 50% in in one Kenyan county and up to 67% nationally in Kenya for Oxytocin, a critical medicine for treating post-partum haemorrhage
Increase in budget absorption
Reduction in procurement turnaround time
Reduction in turnaround time (the time between a requisition and the completion of a contract with a supplier) of 33.3% from an average of 180 to 120 days, improving the ability to use the budget in the budget window as well as the reliability of critical medicines being in stock.
Improvement in procurement effectiveness
An average of 100% improvement in organisational effectiveness over 2 years in 6 counties as measured by independent reviewers
Budget allocation
Advocacy for increased budget allocation led to increases in the budget for healthcare products and technologies of 26-75% across four Kenyan counties.
Debt reduction
Reduction in debt to KEMSA by one country from KES 66 million to KES 0
Improved working capital management
Support for KEMSA to improve working capital management by holding lower stocks and replenishing more frequently (4 times per year vs. once), enabling outgoings to be better match with incoming revenue.
Advocacy for increased budget allocation led to increases in the budget for healthcare products and technologies of 26-75% across four Kenyan counties.
Additionally, CIPS HPA provided technical expertise for a 3-year quantification & forecasting activity that led to the review of HPT budget allocation from $1,059M to $1,548M for 25/26 financial year. (convert to dollars). The 44% budget increment translates to an estimated 6% improvement in product availability
Support for KEMSA to improve working capital management by holding lower stocks and replenishing more frequently (4 times per year vs. once), enabling outgoings to be better match with incoming revenue.
This in turn enables faster payment of suppliers due to better capitalisation. KEMSA has targeted an improvement in speed of supplier payments of three times. KEMSA estimates these changes will result in stock availability of 85%
Talk to CIPS HPA
Please use the form to contact us if you are interested in supporting CIPS HPA activities